8.23 (0.03%)
As of Jan 14, 2022
Source:
We are a precision genetic medicine company dedicated to our mission of developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for individuals who live with disabling hearing loss worldwide. We have built a precision genetic medicine platform that incorporates a proprietary vector library consisting of variants of a small virus commonly used in gene therapy, known as adeno-associated virus, or AAV, and a novel delivery approach.
Country | United States |
Headquarters | boston, massachusetts |
Phone Number | 857-410-1818 |
Industry | manufacturing |
CEO | Emmanuel Simons, Ph.D., M.B.A. |
Website |